نتائج البحث - "Marques, Ana Raquel"

المساهمون: Lille Neurosciences & Cognition - U 1172 (LilNCog), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), Institut du Cerveau = Paris Brain Institute (ICM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Centre d'investigation clinique Neurosciences CHU Pitié Salpêtrière (CIC Neurosciences), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre hospitalier universitaire de Poitiers = Poitiers University Hospital (CHU de Poitiers La Milétrie ), CIC Poitiers – Centre d'investigation clinique de Poitiers (CIC 1402), Université de Poitiers = University of Poitiers (UP)-Centre hospitalier universitaire de Poitiers = Poitiers University Hospital (CHU de Poitiers La Milétrie )-Direction Générale de l'Organisation des Soins (DGOS)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Henri Mondor Créteil, Hôpital Henri Mondor, Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), CHU Louise Michel Clermont-Ferrand, CHU Clermont-Ferrand, Institut Pascal (IP), Centre National de la Recherche Scientifique (CNRS)-Université Clermont Auvergne (UCA)-Institut national polytechnique Clermont Auvergne (INP Clermont Auvergne), Université Clermont Auvergne (UCA)-Université Clermont Auvergne (UCA), Centre d'Investigation Clinique Rennes (CIC), Université de Rennes (UR)-Centre Hospitalier Universitaire de Rennes CHU Rennes = Rennes University Hospital Ponchaillou -Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Rennes CHU Rennes = Rennes University Hospital Ponchaillou, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté COMUE (UBFC), Centre d'investigation clinique de Toulouse (CIC 1436), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Pôle Santé publique et médecine publique CHU Toulouse, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Full financial disclosure: C.M.: advisory board for AbbVie, D.G.: grants from AP-HP (DRC-PHRC) and France Parkinson, served on scientific advisory boards for AbbVie and Zambon, received research funding from Air Liquide and Orkyn, received speech honorarium from Medtronic, Abbvie, Merz, Orkyn, Aguettant and EverPharma, received travel funding from Abbvie and Merz, I.B.: member of the ORKYN scientific board, L.L.M.: research support grants from INSERM, JNLF, The L’Oreal Foundation, the French Parkinson Association, Fondation of France, Paris Brain Institute BBT and Neurocatalyst calls, speech honoraria from CSL, Sanofi-Genzyme, Lundbeck, Teva, consultant for Accure therapeutics, Sanofi and received travel funding from the Movement Disorders Society, ANAINF, Merck, Merz, Medtronic, Teva and AbbVie, E.R.: onorarium for speech from Orkyn, Aguettant, Elivie and for participating in advisory boards from Merz-Pharma, Ipsen and Teva. He received research support from Merz-Pharma, Orkyn, Aguettant, Elivie, Ipsen, Everpharma, Enjoysharing, Fondation Desmarest, AMADYS, ADCY5.org, Fonds de dotation Patrick Brou de Laurière, Agence Nationale de la Recherche, Dystonia Medical Reasearch Foundation, D.D.: Grants : French Ministry of Health: PHRC grants French Ministry of Research: ANR European Preclinical Research: Coen European Clinical Research: Horizon 2020 Charities: France Parkinson, ARSLA Foundation Foundations: University of Lille, CA, Equities: InBrain Pharma, InVenis Biotherapies, G.D.: Honoraria to speak from LVL médical, Elivie, Homeperf, M.B.: grants from France Parkinson Foundation, reimbursement of travel expenses to scientific meetings from Asten, Boston Scientific, Elivie and Medtronic, honoraria from Abbvie, Aguettan, Allergan, Merz Pharma, M.F.: Honoraria to speak from AbbVie, Orkyn and BIAL, consultantancies for LVL médicale.

المصدر: EISSN: 2373-8057 ; npj Parkinson's Disease ; https://hal.science/hal-04329220Test ; npj Parkinson's Disease, 2023, Npj Parkinsons Disease, 9 (1), pp.153. ⟨10.1038/s41531-023-00585-y⟩

مصطلحات موضوعية: [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37919332; hal-04329220; https://hal.science/hal-04329220Test; https://hal.science/hal-04329220/documentTest; https://hal.science/hal-04329220/file/s41531-023-00585-y.pdfTest; PUBMED: 37919332

الإتاحة: https://doi.org/10.1038/s41531-023-00585-yTest
https://hal.science/hal-04329220Test
https://hal.science/hal-04329220/documentTest
https://hal.science/hal-04329220/file/s41531-023-00585-y.pdfTest

View record in BASE

7

دورية أكاديمية

Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial

المؤلفون: Espay, Alberto J, Stocchi, Fabrizio, Pahwa, Rajesh, Albanese, Alberto, Ellenbogen, Aaron, Ferreira, Joaquim J, Giladi, Nir, Gurevich, Tanya, Hassin-Baer, Sharon, Hernandez-Vara, Jorge, Isaacson, Stuart H, Kieburtz, Karl, LeWitt, Peter A, Lopez-Manzanares, Lydia, Olanow, C Warren, Poewe, Werner, Sarva, Harini, Yardeni, Tami, Adar, Liat, Salin, Laurence, Lopes, Nelson, Sasson, Nissim, Case, Ryan, Rascol, Olivier, Afshari, Mitra, Amelin, Alexander, Arkadir, David, Badarny, Samih, Balaguer Martinez, Ernest, Bogucki, Andrzej, Boyd, James, Buyan Dent, Laura, Carroll, Camille, Chaudhuri, Kallol Ray, Cooney, Jeffrey, Corbillé, Anne-Gaëlle, Danaila, Teodor, De Pandis, Maria Francesca, Dethy, Sophie, Dhall, Rohit, Djaldetti, Ruth, Durif, Franck, Flitman, Stephen, Freire Alvarez, Eric, Goudreau, John, Grandas Perez, Francisco, Isa, Arnaldo, Juncos, Jorge L, Kanchana, Sulada, Klodowska-Duda, Gabriela, Koziorowski, Dariusz, Kulisevsky Bojarski, Jaime, Lopez Lozano, Juan, Luo, Lan, Lytvynenko, Nataliya, Marconi, Roberto, Marques, Ana Raquel, Martinez Castrillo, Juan Carlos, Martinez Torres, Irene, Mentreddi, Aashoo, Mir Rivera, Pablo, Moskovko, Sergii, Neryanova, Yuliya, Onofrj, Marco, Ostrem, Jill, Pacchetti, Claudio, Pavese, Nicola, Pellicano, Clelia, Revuelta, Gonzalo, Rodrigues, Ana Margarida, Rodriguez, Ramon, Rudzinska, Monika, Sarwar, Nighat, Schwartzbard, Julie, Scorr, Laura, Slevin, John, Slobodin, Tatyana, Spalletta, Gianfranco, Tagliati, Michele, Tai, Yen, Tessitore, Alessandro, Valkovic, Peter, Verhagen, Leo, Vostrikova, Elena, Yahalom, Gilad, Zalyalova, Zuleykha, Zarubova, Katerina, Zhukova, Irina

العلاقة: https://www.sciencedirect.com/journal/the-lancet-neurologyTest; Lancet Neurol. 2024 May;23(5):465-476; http://hdl.handle.net/10451/64632Test

الإتاحة: https://doi.org/10.1016/S1474-4422Test(24)00052-8
http://hdl.handle.net/10451/64632Test

View record in BASE

8

دورية أكاديمية

Trial of Deferiprone in Parkinson's Disease

المؤلفون: Devos, David, Labreuche, Julien, Rascol, Olivier, Corvol, Jean-Christophe, Duhamel, Alain, Guyon Delannoy, Pauline, Poewe, Werner, Compta, Yaroslau, Pavese, Nicola, Růžička, Evžen, Dušek, Petr, Post, Bart, Bloem, Bastiaan R., Berg, Daniela, Maetzler, Walter, Otto, Markus, Habert, Marie-Odile, Lehericy, Stéphane, Ferreira, Joaquim, Dodel, Richard, Tranchant, Christine, Eusebio, Alexandre, Thobois, Stéphane, Marques, Ana-Raquel, Meissner, Wassilios G., Ory-Magne, F., Walter, Uwe, De Bie, Rob M.A., Gago, Miguel, Vilas, Dolores, Kulisevsky, Jaime, Januario, Cristina, Coelho, Miguel V.S., Behnke, Stefanie, Worth, Paul, Seppi, Klaus, Ouk, Thavarak, Potey, Camille, Leclercq, Céline, Viard, Romain, Kuchcinski, Gregory, Lopes, Renaud, Pruvo, Jean-Pierre, Pigny, Pascal, Garçon, Guillaume, Simonin, Ophelie, Carpentier, Jessica, Rolland, Anne-Sophie, Nyholm, Dag, Scherfler, Christoph, Mangin, Jean-François, Chupin, Marie, Bordet, Regis, Dexter, David T., Fradette, Caroline, Spino, Michael, Tricta, Fernando, Ayton, Scott, Bush, Ashley I., Devedjian, Jean-Christophe, Duce, James A., Cabantchik, Ioav, Defebvre, Luc, Deplanque, Dominique, Moreau, caroline

المساهمون: Université de Lille, CHU Lille, Institut Pasteur de Lille, Département de Pharmacologie Médicale Lille Pôle Recherche, Lille Neurosciences & Cognition - U 1172 LilNCog, Centre d'investigation clinique de Toulouse CIC 1436, 542029|||Institut du Cerveau = Paris Brain Institute ICM (VALID), CHU Lille - Direction de la recherche et de l’innovation, Innsbruck Medical University = Medizinische Universität Innsbruck IMU, Universitat de Barcelona UB, Institut d'Investigacions Biomèdiques August Pi i Sunyer IDIBAPS, Centro de Investigacion Biomédica en Red sobre Enfermedades Neurodegenerativas CIBERNED, Newcastle University Newcastle, 1. lékařská fakulta, Univerzita Karlova Praha, Česká republika = First Faculty of Medicine, Charles University Prague, Czech Republic 1. LF UK / 1st Faculty of Medicine, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center Nijmegen, Christian-Albrechts-Universität zu Kiel = Christian-Albrechts University of Kiel = Université Christian-Albrechts de Kiel CAU, Universität Ulm - Ulm University Ulm, Allemagne, Sorbonne Université SU, Centre d'Acquisition et de Traitement des Images Paris = CATI Multicenter Neuroimaging Platform CATI, Institut du Cerveau = Paris Brain Institute ICM, Universidade de Lisboa, Universität Duisburg-Essen = University of Duisburg-Essen Essen, Fédération de Médecine Translationnelle de Strasbourg FMTS, Institut de Neurosciences de la Timone INT, Aix Marseille Université AMU, Institut des sciences cognitives Marc Jeannerod - Centre de neuroscience cognitive - UMR5229 ISC-MJ, Université Claude Bernard Lyon 1 UCBL, Université Clermont Auvergne UCA, University of Otago Dunedin, Nouvelle-Zélande, Institut des Maladies Neurodégénératives Bordeaux IMN, University of Rostock, Amsterdam University Medical Centers Amsterdam UMC, Universidade do Minho = University of Minho Braga, Germans Trias i Pujol University Hospital Badalona, Barcelona, Spain GTPUH, Universitat Autònoma de Barcelona UAB, Hospitais da Universidade de Coimbra H.U.C., Hospital de Santa Maria Lisboa, Saarland University Hospital UKS, Addenbrooke's Hospital, Centre Hospitalier Régional Universitaire CHU Lille CHRU Lille, Services de neuroradiologie Lille, Service de neuroradiologie Lille, IMPact de l'Environnement Chimique sur la Santé humaine (IMPECS) - ULR 4483, Impact de l'environnement chimique sur la santé humaine - ULR 4483 IMPECS, Uppsala University, Building large instruments for neuroimaging: from population imaging to ultra-high magnetic fields BAOBAB, 444929|||Centre d'Acquisition et de Traitement des Images Paris = CATI Multicenter Neuroimaging Platform CATI (VALID), University of Toronto, Chiesi SAS, University of Melbourne, The Florey Institute of Neuroscience and Mental Health, The Hebrew University of Jerusalem HUJ, Département de neurologie Lille, Lille Neurosciences & Cognition (LilNCog) - U 1172

مصطلحات موضوعية: Parkinson Disease, Hematology/Oncology, Neuroscience, Geriatrics/Aging

وصف الملف: application/octet-stream

العلاقة: info:eu-repo/grantAgreement/633190/EU/Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone/FAIR-PARK-II; New England Journal of Medicine; N Engl J Med; http://hdl.handle.net/20.500.12210/88411Test

الإتاحة: https://doi.org/20.500.12210/88411Test
https://hdl.handle.net/20.500.12210/88411Test

View record in BASE